The genetic mystique of ‘me’ medicine
By Donna Dickenson,
The Globe and Mail
| 08. 28. 2010
[Opinion]
We are on the leading edge of a true revolution in medicine," Francis Collins, director of the U.S. National Institutes of Health, says in his new book, The Language of Life: DNA and the Revolution in Personalized Medicine - "one that promises to transform the traditional 'one size fits all' approach into a much more powerful strategy that considers each individual as unique and as having special characteristics that should guide an approach to staying healthy. But you have to be ready to embrace this new world."
This seismic shift toward genetic personalized medicine promises to give each of us insight into our deepest personal identity - our genetic selves - and let us sip the elixir of life in the form of individually tailored testing and drugs. But can we really believe these promises?
Genetic personalized medicine isn't the only important new development. Commercial ventures such as private blood banks play up the uniqueness of your baby's umbilical-cord blood. Enhancement technologies such as deep-brain stimulation - "Botox for the brain" - promote the idea that you have a duty...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
